Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCIG for Non-Motor Symptoms in Advanced Parkinson's Disease
NCT01736176Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by AbbVie Inc.. Started Mar 2013; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01736176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736176.